Attributes | Values |
---|
rdf:type
| |
Description
| - Low-dose acyclovir prophylaxis for bortezomib-induced herpes zoster in multuple myeloma patients Anotace anglicky: In a cohort of 169 patients with multiple myeloma, treated at our department with bortezomib-based chemotherapy, we assessed the incidence of herpes zoster reactivation in patients with and without low dose acyclovir (200mg once daily) prophylaxis. In 78 patients ( 46%) without any prophylaxis, herpes zoster occured in 21 cases (27%). In 92 patients (54%) with low-dose acyclovir prophylaxis there was only one case of herpes zoster in a patient with skipped medication. Most patients with herpes zoster underwent the reactivation within the first three cycles of the treatment. Low-dose acyclovir in multiple myeloma patients treated with bortezomib creates a sufficient prophylaxis of herpes zoster reactivation.
- Low-dose acyclovir prophylaxis for bortezomib-induced herpes zoster in multuple myeloma patients Anotace anglicky: In a cohort of 169 patients with multiple myeloma, treated at our department with bortezomib-based chemotherapy, we assessed the incidence of herpes zoster reactivation in patients with and without low dose acyclovir (200mg once daily) prophylaxis. In 78 patients ( 46%) without any prophylaxis, herpes zoster occured in 21 cases (27%). In 92 patients (54%) with low-dose acyclovir prophylaxis there was only one case of herpes zoster in a patient with skipped medication. Most patients with herpes zoster underwent the reactivation within the first three cycles of the treatment. Low-dose acyclovir in multiple myeloma patients treated with bortezomib creates a sufficient prophylaxis of herpes zoster reactivation. (en)
|
Title
| - Low-dose acyclovir prophylaxis for bortezomib-induced herpes zoster in multuple myeloma patients
- Low-dose acyclovir prophylaxis for bortezomib-induced herpes zoster in multuple myeloma patients (en)
|
skos:prefLabel
| - Low-dose acyclovir prophylaxis for bortezomib-induced herpes zoster in multuple myeloma patients
- Low-dose acyclovir prophylaxis for bortezomib-induced herpes zoster in multuple myeloma patients (en)
|
skos:notation
| - RIV/00098892:_____/12:#0000263!RIV13-MZ0-00098892
|
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| |
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/00098892:_____/12:#0000263
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - multiple myeloma, bortezomib, herpes zoster, acyclovir, prophylaxis (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - GB - Spojené království Velké Británie a Severního Irska
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| - British Journal of Haematology
|
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Pika, Tomáš
- Minařík, Jiří
|
issn
| |
number of pages
| |